Wire · regulatory
NEWS: Cantwell, Grassley Urge FTC to Finish Investigation into Pharmacy Benefit ...
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 26 October 2026 · Fusion42 review
U.S. Senators Maria Cantwell and Chuck Grassley are urging the FTC to complete and publicly release its investigation into pharmacy benefit managers' (PBMs) business practices. The senators emphasize the need for a final report to assess whether current antitrust laws adequately regulate PBMs to lower drug costs and protect market competition.
This Wire brief sits within Fusion42's coverage of Health, and 1 source has reported it between 22 Oct 2026 and 26 Oct 2026.
◆ ◆ The Wire takeaway
Congress is close to receiving a full FTC report that could tighten oversight of pharmacy benefit managers and reshape drug pricing rules. You need to track this to adjust compliance and market strategies around PBM-driven drug costs.
◆ Coverage
1 source · first reported 22 Oct 2026 · latest 26 Oct 2026
◆ Related on Wire
◆ Topics